June 2012 Eric Christensen Patient-centered Medical Home (PCMH)/ Medical Home Port (MHP) Evaluation (with emphasis on chronic conditions, particularly.

Slides:



Advertisements
Similar presentations
1 TennCare Diabetes Program Evaluation Presentation to AcademyHealth Kenton Johnston, MPH, MS, MA June 4, 2007 An Individually-Matched Control Group Evaluation.
Advertisements

Connecticuts Value Based Insurance Design The Health Enhancement Program for Connecticut State Employees (Covers Active State Employees and Retirees After.
Preventable Hospitalizations: Assessing Access and the Performance of Local Safety Net Presented by Yu Fang (Frances) Lee Feb. 9 th, 2007.
Disease State Management The Pharmacist’s Role
Cost Offsets from Recommended Medications for Medicare Beneficiaries with Diabetes AcademyHealth June 9, 2008 Bruce Stuart,* Linda Simoni-Wastila,* Lirong.
Aetna and PCMH Improving Employee Health through Patient- Centered Medical Homes Morristown, New Jersey October 12, 2010 Aetna’s experience with Patient-Centered.
1 February 9, 2007 Indigent Care Collaboration HIE Supports Community Collaboration February 9, 2007 Ann Kitchen  Executive Director Indigent Care Collaboration.
Pharmacists Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Clinical.
Inappropriate clopidogrel adherence explains stent related adverse outcomes Leonardo Tamariz, MD, MPH University of Miami.
RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.
Holding Health Plans & Providers Accountable for High-Quality, Patient-Centered Care January 23, 2015.
CMS 5 STARS PROGRAM MedPOINT Management.
+ The Effects of Global Primary Care By Kelsey Starck.
Readmission and Chronic illness that could benefit from end of life discussions.
The Facts About Rising Health Care Costs.
Electronic Medical Record Use and the Quality of Care in Physician Offices National Conference on Health Statistics August 17, 2010 Chun-Ju (Janey) Hsiao,
The Big Puzzle Evolving the Continuum of Care. Agenda Goal Pre Acute Care Intra Hospital Care Post Hospital Care Grading the Value of Post Acute Providers.
Care Coordination What is it? How Do We Get Started?
Medicare Advantage Quality Measurement & Performance Assessment Training Conference April 8-9, 2008 Empowering a More Informed Consumer: Medicare Plan.
Evaluation of the TRICARE Program FY 2011 WHAT IS TRICARE? TRICARE is a family of health plans for MHS. TRICARE responds to the challenge of maintaining.
UPMC Matilda Theiss Health Center. UPMC hospital-based clinic  Only federally qualified health center within UPMC Serving a total of 1600 patients 
Memorial Hermann Healthcare System Clinical Integration & Disease Management Dan Wolterman April 15, 2010.
Pharmacy Variation Utilization and variation for maintenance and scheduled drugs Nevin Aragam, CNA Analysis and Solutions.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
Access to Care Where Are We All Going to Get Care? Bruce A. Bishop Senior Counsel/Director of Compliance Northwest Permanente, P.C., Physicians and Surgeons.
Microsoft’s Wellness & Weight Management Programs December 14, 2005 Tom McPherson Senior Benefits Manager.
Naval Health Care New England COMMAND ORIENTATION TRICARE BRIEF HEALTH CARE OPERATIONS NOV 2005.
Association of Health Plan’s HEDIS Performance with Outcomes of Enrollees with Diabetes Sarah Hudson Scholle, MPH, DrPH April 9, 2008.
Patient-Centered Medical Home Overview October 15, 2013.
Pay for Performance in the Context of the Military Patient- Centered Medical Home Michael Dinneen, MD, PhD COL John P. Kugler, MD, MPH Department of Defense.
The Hilltop Institute was formerly the Center for Health Program Development and Management. Emergency Room Use by Individuals with Disabilities Enrolled.
Designing a mobile health intervention for diabetes management in India Fiona Y. Akhtar MBA, MS | Mobile Health Design | June 10, 2013
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
National Commission for Quality Long Term Care Testimony of George Taler, MD Director, Long Term Care Washington Hospital Center Washington, DC Past President,
1 Minnesota Medical Home Project: Evaluation Feasibility Study Saturday, June 7, 2008 SHRIG Meeting, Academy Health.
LOCKTON DUNNING BENEFITS UNIVERSITY OF ALASKA 2ND QTR FY13 UTILIZATION REVIEW 7/1/2012 TO 12/31/2012.
AAACN April 2008 Mary Ramos, PhD, RN The Role of Military Ambulatory Care Nurses in Facilitating the Best Evidence-based Care.
California Pay for Performance: Reporting First Year Results and The Business Case for IT Investment Lance Lang, MD Health Net, California November 18,
New York State Department of Health Hospital-Medical Home Demonstration Reflections, Celebrations and Transformations.
Click to edit Master subtitle style Aetna Behavioral Health Depression Initiatives June 2006.
EmblemHealth Medical Home High Value Network Project William Rollow, MD MPH PCPCC Presentation December 2, 2008.
Academy Health Annual Meeting, Orlando, June 2007 What Accounts for the Rise in Medicare Spending? Kenneth E. Thorpe, Ph.D. Robert W. Woodruff Professor.
3 rd Annual Dean’s Right Care Cardiovascular and Diabetes Leadership Summit Taking Action Together to Prevent Heart Attacks and Strokes Reaching 90th percentile.
Monthly Operating Report February Total Active Enrollment Trend Tiger Teams, % FPL.
The Usual Source of Care and Delivery of Preventive Services to Medicare Beneficiaries Academy Health, June 2005 Hoangmai Pham, MD, MPH Deborah Schrag,
MiPCT Evaluation Update 1 Clare Tanner March 14, 2014.
Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Partnerships.
RESEARCH POSTER PRESENTATION DESIGN © As health care expenditures in the United States rise without concomitant improved.
Care Management: The Transition to Meeting NCQA Standards for PCMH Clyde H. Satterly, MD, MBA SUNY Upstate Medical University, Dept of Family Medicine.
1 million Ga. Medicaid & PeachCare patients to move to HMOs (CMOs); 100,000 elderly & disabled to enter disease management.
Managed Care Nursing Facility Quality Initiatives February 2, 2015.
The Patient Centered Medical Home. Learning Objectives Identify the attributes of a patient centered medical home Describe some processes that facilitate.
Cost-Effectiveness of Treatment Strategies for Comorbid Diabetes and Dyslipidemia Part 2.
Wireless Access SSID: cwag2017
Primary Care: Improving Access in Alberta
Presentation of AMI’s Integrated Chronic Pain Program (ICPP) to CTC-RI’s Clinical Strategy and Cost Committee Richard Sarnat, M.D. – President Linda.
Longitudinal Evaluation of Physician Payment Reform and Team-Based Care on Chronic Disease Management and Prevention NAPCRG Annual Meeting, October 27,
Use of BCBSRI Primary Care Provider Profile to Improve Performance
Charlotte Crist, BS, RN-BC, CCM, CPHQ
Quality in Medicare Phyllis Torda Vice President, Product Development
Tara Kiran1,2, Alex Kopp2, Rick Glazier1,2
ASPIRE Workshop 5: Application of Biostatistics
ASPIRE Workshop 5: Application of Biostatistics
Part 3 of 3 Welcome to this presentation on “Quality Measures in Cholesterol and Diabetes Management.” 1.
Health Home Program Services
Performance Improvement Projects: PIP Library
Medicare and Disease Management
Bridges to Excellence: Recognizing High-Quality Care
ASPIRE Workshop 5: Application of Biostatistics
Presentation transcript:

June 2012 Eric Christensen Patient-centered Medical Home (PCMH)/ Medical Home Port (MHP) Evaluation (with emphasis on chronic conditions, particularly diabetes)

Overview Context –MHS/Navy Medicine moving rapidly to PCMH/MHP models –Literature shows the potential of PCMHs, but success is not automatic –“78% of health spending is devoted to people with chronic conditions”* Purpose –Assess the impact of the Bethesda PCMH on access, quality, and cost –Assess whether the MHP model is effective for different patient types and in different settings Outcome –Resource allocation should consider the effectiveness of MHP model –Which populations to target first with MHP * Anderson and Horvath, “The Growing Burden of Chronic Disease in America,” Public Health Reports, 2004, 119(3):

Topics/outline Results on access and quality –HEDIS metrics –Patient satisfaction survey Results on use and costs –Overall –Chronic versus non-chronic patients –By chronic condition Clinical Practice Guidelines (CPGs) adherence—diabetes Note –Some slides use NNMC and others WRNMMC as some of the work was completed before the Bethesda-Walter Reed merger –Results in this brief are for the WRNMMC internal medicine MHP 3

WRNMMC HEDIS scores (pre- and post-implementation) HEDIS measurePre-periodPost-period Favorable (unfavorable) difference HbA1c test84.5%91.8%7.3% HbA1c > %17.6%8.3% LDL screening78.2%88.6%10.5% LDL-C value < 100 mg/dl53.3%66.1%12.9% Asthmatics appropriately prescribed93.9%96.1%2.2% Pap smear test80.6%87.4%6.8% Mammography screening75.3%82.8%7.5% Colorectal cancer screening60.7%68.5%7.8% 4 Note: The values for the pre-period are monthly averages for January-May 2008 compared to February-December 2009 for the post-period. The transition period was from June 2008 through January 2009.

PCMH impact on access and patient satisfaction 5

How to increase satisfaction and PCM rating? Those reporting high levels of access and provider communication report high satisfaction and PCM rating –Access (OR: 2.1; CI: ) –Provider communication (OR: 1.9; CI: ) Implies that increasing access and provider communication will increase satisfaction and PCM rating –But, how to do this? Drivers of access –Ease of scheduling appointments (OR: 4.6; CI: ) –Ability to get appt for routine care when needed (OR: 4.4; CI: ) –Ability to get appt for urgent care when needed (OR: 3.7; CI: ) Drivers of provider communication –PCM listens carefully (OR: 13.5; CI: ) –PCM provides complete and accurate info (OR: 12.9; CI: ) 6

Use and cost analysis Conducted retrospective data analysis (FY07-10) –Transition period from June 2008 to January 2009 Used differences-in-differences approach Used two-step process for analyzing health care use and costs –Step 1: binary regression for user or non-user of a particular service –Step 2: OLS regression for amount of services for users only Used NMC Portsmouth, NMC San Diego, and NHP Pensacola internal medicine clinics as comparison sites Focused on chronic conditions –Diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), and mental health 7

PCMH impact on use – all enrollees 8

PCMH impact on use – chronic patients 9

PCMH impact on use – non-chronic patients 10

PCMH impact on cost – all enrollees 11

PCMH impact on cost – chronic patients 12

PCMH impact on cost – non-chronic patients 13

Cost impacts associated with chronic enrollees Chronic Non- chronicTotal Change attributable to chronic enrollees Estimated costs per enrollee PMPY without PCMH$3,136$750 PMPY with PCMH$2,803$697 Change in dollars-$333-$53 Change in percentages-10.6%-7.1% Average PMPY change by percent of enrollees with chronic conditions 40%-$ % 50%-$ % 60%-$ % 14

WRNMMC PCMH impact by condition Diabetes Hyper- tension Hyper- lipidemiaCOPDCAD Mental health Inpatient admissions-10.8% Inpatient days20.2%19.0%36.0% ER visits-13.5% Specialty care-3.6%-0.5%3.4% Primary care40.3%32.0%32.1%46.3%49.3%24.8% Pharmacy-17.0%-16.1%-17.0%-10.3%NA*-1.4% Ancillary-16.2%-19.1%-15.2%-24.0%-24.1%-14.1% PMPQ-10.5%-11.1%-10.0%-10.1%-8.2% WRNMMC enrollees1,5957,0987, ,426 *Model would not converge. 15

Diabetes CPG metrics Screening/exam –HbA1c exam (at least yearly) –Eye exam (every two years) –Lipid (LDL-C) screening (yearly) –Nephropathy (yearly) Level/control –HbA1c control (> 9.0%) –Lipid control (LDL-C < 100 mg/dL) –Blood pressure control 16

Diabetes CPG adherence rates—HbA1c exam 17

Diabetes CPG adherence rates—eye care 18

Diabetes CPG adherence rates—lipid control 19

Diabetes CPG adherence rates—nephropathy 20

Are changes in CPG adherence rates significant? Controlling for demographic differences and other chronic conditions, PCMH patients are more likely to have yearly nephrology and lipid control panels than patients at control sites HbA1c results are not meaningful because of the change in coding practice at WRNMMC in 2010 Eye exams are recommended every two years, but with a 1-year comparison (2007 to 2010), there is a significant decline in patients receiving eye exams 21 Procedure Odds ratio for post-PCMH Significance Nephrology Lipid control

22 Staff survey – continuity and coordination of care How often do you feel that you can exercise autonomy as opposed to having to utilize a standard procedure? –The question was only asked of providers

Enrollment status of diabetics (Navy catchment areas) 23

Chronic disease burden “78% of health spending is devoted to people with chronic conditions. Quality medical care for people with chronic conditions requires a new orientation toward prevention of chronic disease and provision of ongoing care and care management to maintain health status and functioning.” –Health spending attributable to people with chronic conditions  1 or more conditions: 88% for prescriptions, 72% for physician visits, 76% for inpatient  2 or more conditions: 67% for prescriptions, 48% for physician visits, 56% for inpatient Source: Anderson and Horvath, “The Growing Burden of Chronic Disease in America,” Public Health Reports, 2004, 119(3):

Pharmacy Variation Utilization and variation for maintenance and scheduled drugs Nevin Aragam, CNA Analysis and Solutions

Outline We investigate Navy pharmacy utilization and variation for FY 2011 to identify and understand patterns among our population of maintenance and scheduled pharmaceutical users  Methods  All drugs  Maintenance drugs  Scheduled drugs FOR OFFICIAL USE ONLY 26

Methods FY 2011 PDTS via MDR Used catchment area of record to identify the eligible populations surrounding navy catchment regions Identified all eligible beneficiaries in FY 2011 using DEERS and the demographic information from the most recent FM the beneficiary appeared Maintenance drugs are identified with the MDR PDTS field Maintenance Drug = ‘Y’ Scheduled drugs and identified using the MDR PDTS field DEA Class = 1, 2, 3, 4, or 5* FOR OFFICIAL USE ONLY 27 * note, there were no drugs identified as having DEA class 1 in PDTS

All pharmacy age distribution FOR OFFICIAL USE ONLY 28 Age distribution for all pharmacy users

FOR OFFICIAL USE ONLY 29 All pharmacy utilization 30 day supplies per 1,000 Navy region beneficiaries by age 60, days supplies implies the average 80 year old takes about 5 medications daily

FOR OFFICIAL USE ONLY 30 Popular fill source AD beneficiaries fill almost exclusively at MTF pharmacies Active duty family members and retirees fill mostly at MTFs and a sizable proportion at retail pharmacies Retirees and their dependents fill fairly evenly across MTFs and retail pharmacies Source System ADADFMRET RETDEP/ OtherTotal Direct93.6%61.3%48.4%40.1%53.8% Retail5.3%37.4%40.6%50.9%39.2% Mail order0.3%0.7%6.4%5.3%4.1% Other0.8%0.6%4.5%3.6%3.0% Total100.0% Source: MHS Data Repository (MDR PDTS table FY2011).

Types of maintenance drugs Top 5 Maintenance drugs (15% of all maintenance drugs prescribed) 1.IBUPROFEN 2.SIMVASTATIN 3.LISINOPRIL 4.NEXIUM 5.LIPITOR FOR OFFICIAL USE ONLY 31

FOR OFFICIAL USE ONLY 32 Maintenance drug age distribution Age distribution for maintenance pharmaceutical users

FOR OFFICIAL USE ONLY 33 Maintenance drug utilization 30 day supplies of maintenance drugs per 1,000 Navy region beneficiaries by age 50, days supplies implies the average 80 year old takes about 4 maintenance medications daily

FOR OFFICIAL USE ONLY 34 Maintenance drug regional variation High: NH Pensacola (13, day supplies) Low: NCA MSMA (9, day supplies) High/Low: 1.41 (Beneficiaries in NH Pensacola use 1.4 times as many maintenance drugs as those in the NCA MSMA) Regional variation for maintenance drug prescriptions per 1,000 beneficiaries

Scheduled drugs FOR OFFICIAL USE ONLY 35 ScheduleAbuse potential Accepted medical use Likelihood of psychological or physical Dependence Examples IHighNoNo accepted safety for use Heroin, LSD, marijuana IIHighYesHighAmphetamine (Adderall ® ), methamphetamine (Desoxyn ® ), cocaine IIIModerateYesModerateVicodin ®, Tylenol with codeine ®, ketamine IVLowYesLimitedAlprazolam (Xanax ® ), diazepam (Valium ® ) VLowYesLimited Robitussin AC ®,Phenergan with Codeine ®

Types of scheduled drugs Top 5 Scheduled drugs (55% of all schedules drugs prescribed) 1.HYDROCODONE-ACETAMINOPHEN 2.ZOLPIDEM TARTRATE 3.OXYCODONE-ACETAMINOPHEN 4.ALPRAZOLAM 5.DIAZEPAM Scheduled drugs can also be maintenance drugs: 1.CLONAZEPAM 2.CONCERTA 3.LYRICA 4.ADDERALL XR 5.VYVANSE FOR OFFICIAL USE ONLY 36

FOR OFFICIAL USE ONLY 37 Scheduled drug age distribution Age distribution for scheduled pharmaceutical users

FOR OFFICIAL USE ONLY 38 Scheduled drug utilization 30 day supplies of scheduled drugs per 1,000 Navy region beneficiaries by age 1, days supplies implies the average 80 year old takes about 1.5 scheduled drug medications daily

FOR OFFICIAL USE ONLY 39 Scheduled drug regional variation High: NH Pensacola (1, day supplies) Low: NCA MSMA ( day supplies) High/Low: 1.89 (Beneficiaries in NH Pensacola use nearly twice as many scheduled drugs as those in the NCA MSMA) Regional variation for scheduled drug prescriptions per 1,000 beneficiaries

FOR OFFICIAL USE ONLY 40 Questions? Nevin Aragam

Appendix Navy region definitions by catchment area DMIS ID: NCA MSMA – Tide Water MSMA San Diego MSMA Puget Sound MSMA NH Beaufort NH Camp Lejeune NH Jacksonville NH Lemoore NH Pensacola NH Twentynine Palms FOR OFFICIAL USE ONLY 41